Your browser doesn't support javascript.
loading
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Vitale, Candida; Salvetti, Chiara; Griggio, Valentina; Porrazzo, Marika; Schiattone, Luana; Zamprogna, Giulia; Visentin, Andrea; Vassallo, Francesco; Cassin, Ramona; Rigolin, Gian Matteo; Murru, Roberta; Laurenti, Luca; Rivela, Paolo; Marchetti, Monia; Pennese, Elsa; Gentile, Massimo; Boccellato, Elia; Perutelli, Francesca; Montalbano, Maria Chiara; De Paoli, Lorenzo; Reda, Gianluigi; Orsucci, Lorella; Trentin, Livio; Cuneo, Antonio; Tedeschi, Alessandra; Scarfò, Lydia; Gaidano, Gianluca; Mauro, Francesca Romana; Foà, Robin; Boccadoro, Mario; Coscia, Marta.
Afiliação
  • Vitale C; Department of Molecular Biotechnology and Health Sciences, University of Torino-Division of Hematology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.
  • Salvetti C; Department of Molecular Biotechnology and Health Sciences, University of Torino-Division of Hematology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.
  • Griggio V; Department of Molecular Biotechnology and Health Sciences, University of Torino-Division of Hematology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.
  • Porrazzo M; Division of Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Rome, Italy.
  • Schiattone L; Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), B-Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Zamprogna G; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padua, Italy.
  • Vassallo F; Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Cassin R; Hematology Unit, IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Rigolin GM; Hematology Section, Department of Medical Sciences, AOU Arcispedale S Anna, University of Ferrara, Ferrara, Italy.
  • Murru R; Hematology and Stem Cell Transplantation Unit, Ospedale A Businco, Cagliari, Italy.
  • Laurenti L; Institute of Hematology, Fondazione Policlinico Universitario A Gemelli, Rome, Italy.
  • Rivela P; Hematology Department, Azienda Ospedaliera (AO) SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Marchetti M; Hematology Department, Azienda Ospedaliera (AO) SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Pennese E; Unità Operativa Semplice Dipartimentale (UOSD) Centro Diagnosi e Terapia dei Linfomi, Dipartimento Oncologico-Ematologico, Presidio Ospedaliero "Spirito Santo," Pescara, Italy.
  • Gentile M; Hematology Unit, and Biotechnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Boccellato E; Department of Molecular Biotechnology and Health Sciences, University of Torino-Division of Hematology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.
  • Perutelli F; Department of Molecular Biotechnology and Health Sciences, University of Torino-Division of Hematology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.
  • Montalbano MC; Department of Molecular Biotechnology and Health Sciences, University of Torino-Division of Hematology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.
  • De Paoli L; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; and.
  • Reda G; Hematology Unit, IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Orsucci L; Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Trentin L; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padua, Italy.
  • Cuneo A; Hematology Section, Department of Medical Sciences, AOU Arcispedale S Anna, University of Ferrara, Ferrara, Italy.
  • Tedeschi A; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Scarfò L; Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), B-Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Gaidano G; Università Vita Salute San Raffaele, Milan, Italy.
  • Mauro FR; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; and.
  • Foà R; Division of Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Rome, Italy.
  • Boccadoro M; Division of Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Rome, Italy.
  • Coscia M; Department of Molecular Biotechnology and Health Sciences, University of Torino-Division of Hematology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy.
Blood ; 137(25): 3507-3517, 2021 06 24.
Article em En | MEDLINE | ID: mdl-33651883

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Imunossupressores Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Imunossupressores Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article